U.S. Other Utilities Stock News

If you are wondering whether Eli Lilly's share price still makes sense at current levels, you are not alone. This article is here to unpack what you are really paying for. The stock closed at US$1,040.00, with returns of 0.2% over 30 days, a 3.7% decline year to date, and a 24.1% gain over the last year. The 3 year return is very large at about 3x. Recent attention around Eli Lilly has focused on its position in large cap pharmaceuticals, including market interest in its drug portfolio and...

In early February 2026, Camden Property Trust reported higher fourth-quarter and full-year 2025 earnings, recorded a US$12,916,000 land-related impairment, issued 2026 EPS guidance of US$0.22–US$0.26 for the first quarter and US$0.40–US$0.70 for the year, raised its quarterly dividend to US$1.06 per share, and authorized up to US$600,000,000 of new share repurchases. Taken together, stronger reported profitability, a larger dividend, and fresh buyback capacity point to management’s current...

In the past few days, law firm Halper Sadeh LLC announced an investigation into whether Hut 8 Corp.’s officers and directors breached fiduciary duties to long-term shareholders, while also inviting investors to seek potential governance-related remedies. At the same time, Hut 8’s short interest has climbed to a higher level than many peers, highlighting increased bearish positioning and growing scrutiny of the company’s leadership and business outlook. Against this backdrop of a governance...

PG&E (PCG) is back in focus after reporting full year 2025 results, with higher revenue, net income, and earnings per share, along with another year of double digit core EPS growth and tighter 2026 guidance. See our latest analysis for PG&E. That earnings update appears to be landing well with investors, with the share price at $18.16 and a 7 day share price return of 11.07%, building on a 30 day gain of 16.34% and a 1 year total shareholder return of 19.73%. This suggests momentum has...

In early February 2026, Ford Motor reported full-year 2025 revenue of US$187,267 million but swung to a net loss of US$8,182 million, while also outlining 2026 guidance and confirming plans for additional combustion-powered and electric utes, including a new mid-size EV truck targeted around US$30,000. Alongside this weak profitability and tariff-related headwinds, Ford filed a universal shelf registration and continued investing in its Ford+ plan, signaling it may balance short-term...

In early February 2026, McKesson Corporation reported third-quarter 2025 results showing higher sales of US$106.16 billion and increased net income of US$1.19 billion versus the prior year, alongside continued share repurchases and a new universal shelf registration filing. The company’s stronger earnings per share from continuing operations and ongoing reduction in shares outstanding highlight management’s focus on improving per-share financial performance and maintaining financial...

Comcast (CMCSA) is in focus after completing a series of broadband buildouts across Indiana, West Virginia, Pennsylvania, and Washington, adding thousands of newly connected homes and businesses to its high-speed internet footprint. See our latest analysis for Comcast. All these broadband expansions come as Comcast’s share price sits at US$31.57, with a 30 day share price return of 13.48% and year to date gain of 6.87%. The 1 year total shareholder return is slightly negative and the longer...

CBL & Associates Properties recently reported fourth-quarter and full-year 2025 results showing higher revenue and net income versus the prior year, alongside 2026 earnings guidance and confirmation of its regular cash dividend for the quarter ended March 31, 2026. Beyond the headline numbers, the company highlighted balance sheet improvements, selective asset sales, and acquisitions of four dominant enclosed malls, signaling an emphasis on reshaping its retail real estate portfolio. Next,...

NNN REIT, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher revenue of US$238.40 million for the quarter and US$926.21 million for the year, alongside slightly lower net income and earnings per share versus 2024. The company also highlighted its 36th consecutive year of dividend growth, ongoing portfolio recycling with over US$900 million of acquisitions and US$190.50 million of property sales, and issued 2026 guidance for both net earnings per share and...

In February 2026, LuxExperience B.V. reported second-quarter sales of €646.92 million and a net loss of €12.64 million, while also updating full-year 2026 guidance to target GMV between €2.5 billion and €2.7 billion under its ongoing transformation plan. The combination of strong year-on-year sales growth and tighter guidance ranges highlights management’s confidence in executing its operational overhaul despite continued losses. With LuxExperience tightening full-year GMV guidance, we’ll...

Illinois Tool Works Inc. recently reported fourth-quarter 2025 results showing higher sales of US$4,093 million and net income of US$790 million year-on-year, while also detailing full-year 2025 performance and share repurchases totaling US$3.01 billions since August 2023. In addition, the company declared a first-quarter 2026 dividend of US$1.61 per share, equivalent to US$6.44 on an annualized basis, underscoring its continued emphasis on returning cash to shareholders through both...

Rush Street Interactive (RSI) is back in focus after CEO Richard Todd Schwartz sold 247,114 shares on February 4, trimming his direct stake to about 0.97% ahead of the upcoming Q4 FY2025 earnings release. See our latest analysis for Rush Street Interactive. At a share price of US$16.03, Rush Street Interactive has seen momentum cool recently, with a 30 day share price return of 16.94% and a year to date share price return of 16.99%, even though the 3 year total shareholder return sits at a...

Crane (CR) is back in focus after a quarterly operating update that detailed segment performance, manufacturing efficiency, and a routine distribution announcement, prompting investors to reassess the stock following a strong multiyear total return profile. See our latest analysis for Crane. At a share price of $200.52, Crane’s 90 day share price return of 11.72% and year to date share price return of 6.93% sit alongside a 1 year total shareholder return of 17.54% and very strong multi year...

Why Regency Centers Is Back on Investor Radars Regency Centers (REG) has drawn fresh attention after reporting fourth quarter and full year 2025 results that showed higher sales, revenue, and net income, alongside new 2026 earnings guidance outlining management's expectations. See our latest analysis for Regency Centers. At a share price of US$76.18, Regency Centers has logged a 30 day share price return of 6.59% and a 90 day share price return of 9.63%. Its 5 year total shareholder return of...

In recent weeks, Disney has taken legal action against ByteDance, issuing a cease-and-desist letter that challenges the use of Disney characters and other intellectual property in training ByteDance’s AI video generator, Seedance 2.0, as generative AI tools spread across online platforms. This dispute highlights how Disney is actively testing and defending new licensing models for its content in the AI era, especially after its separate deal allowing OpenAI to use Disney IP in AI video...

DigitalOcean Holdings (DOCN) is back in focus after a recent upgrade to Overweight, as Cantor Fitzgerald highlighted the company’s progress in scaling its cloud platform and attracting larger customers such as Character.ai. See our latest analysis for DigitalOcean Holdings. The upgrade appears to have come as momentum was already building, with a 1 month share price return of 29.19%, a 90 day share price return of 54.87%, and a 1 year total shareholder return of 53.13% pointing to strong...

Azenta stock performance snapshot after recent moves Azenta (AZTA) has seen mixed returns recently, with the share price up 1.8% over the past day but down over the past week, month, past 3 months and year. See our latest analysis for Azenta. That 1.8% one day share price gain comes after a tougher stretch, with a 30 day share price return of 28.45% and a 1 year total shareholder return of 36.97%. This suggests momentum has been fading rather than building. If Azenta's recent weakness has you...

What recent performance says about New Oriental Education & Technology Group New Oriental Education & Technology Group (EDU) has drawn investor attention after a period where the stock moved roughly 6% over the past month and about 10% over the past 3 months. Those returns sit alongside a 1 day decline of about 2.6% and a 7 day decline of roughly 2.3%. This combination can prompt investors to look more closely at the company’s fundamentals and recent financial metrics. See our latest analysis...

Exelixis recently reported past fourth-quarter 2025 revenue of US$598.66 million and net income of US$244.53 million, with full-year 2025 revenue of US$2.32 billion and net income of US$782.57 million, alongside higher basic and diluted earnings per share from continuing operations versus the prior year. At the same time, the FDA accepted Exelixis’s New Drug Application for zanzalintinib plus atezolizumab in previously treated metastatic colorectal cancer, signaling regulatory progress that...

In recent months, Quantum Computing Inc. completed the US$110.0 million cash acquisition of Luminar Semiconductor, expanding its photonic technology portfolio, patent base and engineering capabilities to better address government and defense-related demand. At the same time, Quantum Computing Inc. has become one of the most heavily shorted mid-to-mega cap technology names, with very large short interest intensifying attention on its limited revenues, frequent equity raises and insider...

Relay Therapeutics recently announced that the U.S. FDA granted Breakthrough Therapy designation to its PI3Kα inhibitor zovegalisib (RLY-2608) in combination with fulvestrant for adults with PIK3CA‑mutant HR+/HER2‑ locally advanced or metastatic breast cancer after CDK4/6 inhibitor treatment, supported by Phase 1/2 ReDiscover trial data and an ongoing Phase 3 study. This regulatory milestone not only accelerates FDA feedback and review timelines but also highlights zovegalisib’s potential...

What IPG Photonics’ recent performance could mean for investors IPG Photonics (IPGP) has drawn attention after a strong run, with the stock showing gains over the past week, month and past 3 months, alongside reported annual revenue of US$1,003.8m and net income of US$31.1m. See our latest analysis for IPG Photonics. The recent surge in IPG Photonics’ share price, with a 30 day share price return of 88.3% and a year to date share price return of 105.7%, contrasts with a 5 year total...

Agilent Technologies (A) just secured U.S. FDA approval for its PD-L1 IHC 22C3 pharmDx test in first line ovarian and related cancers, extending the assay’s use as a companion diagnostic for Merck’s Keytruda. See our latest analysis for Agilent Technologies. Agilent’s latest FDA approval and ongoing automation push come while the 1 month share price return of 9.9% decline and 3 year total shareholder return of 13.24% decline signal pressure on both short and long term performance, suggesting...

In the third quarter, Allianz Asset Management GmbH initiated a new position in Ingevity, purchasing 30,268 shares valued at approximately US$1,670,000, alongside broader institutional trading that has brought institutional ownership to 91.59% of the company’s stock. Along with this high level of institutional participation, Ingevity’s recent quarterly earnings release has drawn heightened attention to how professional investors may be repositioning ahead of evolving fundamentals. With...